These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28886811)

  • 21. 31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration.
    Bailey CN; Martin BJ; Petkov VI; Schussler NC; Stevens JL; Bentler S; Cress RD; Doherty JA; Durbin EB; Gomez SL; Gonsalves L; Hernandez BY; Liu L; Morawski BM; Schymura MJ; Schwartz SM; Ward KC; Wiggins C; Wu XC; Goldberg MS; Siegel JJ; Cook RW; Covington KR; Kurley SJ
    JCO Precis Oncol; 2023 Jun; 7():e2300044. PubMed ID: 37384864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of gene expression profiling on diagnosis and survival after metastasis in patients with uveal melanoma.
    Suwajanakorn D; Lane AM; Go AK; Hartley CD; Oxenreiter M; Wu F; Gragoudas ES; Sullivan RJ; Montazeri K; Kim IK
    Melanoma Res; 2024 Aug; 34(4):319-325. PubMed ID: 38578293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Technological advances for the detection of melanoma: Advances in molecular techniques.
    Fried L; Tan A; Bajaj S; Liebman TN; Polsky D; Stein JA
    J Am Acad Dermatol; 2020 Oct; 83(4):996-1004. PubMed ID: 32360759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating the melanoma 31-gene expression profile test with surgical oncology practice within national guideline and staging recommendations.
    Hyams DM; Covington KR; Johnson CE; Plasseraud KM; Cook RW
    Future Oncol; 2021 Feb; 17(5):517-527. PubMed ID: 33021104
    [No Abstract]   [Full Text] [Related]  

  • 25. Association between traditional clinical high-risk features and gene expression profile classification in uveal melanoma.
    Nguyen BT; Kim RS; Bretana ME; Kegley E; Schefler AC
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):421-427. PubMed ID: 29185101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients.
    Cook RW; Middlebrook B; Wilkinson J; Covington KR; Oelschlager K; Monzon FA; Stone JF
    Diagn Pathol; 2018 Feb; 13(1):13. PubMed ID: 29433548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variable Results for Uveal Melanoma-Specific Gene Expression Profile Prognostic Test in Choroidal Metastasis.
    Klufas MA; Itty S; McCannel CA; Glasgow BJ; Moreno C; McCannel TA
    JAMA Ophthalmol; 2015 Sep; 133(9):1073-6. PubMed ID: 26086628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrating Skin Cancer-Related Technologies into Clinical Practice.
    Winkelmann RR; Farberg AS; Glazer AM; Cockerell CJ; Sober AJ; Siegel DM; Leachman SA; High WA; Markowitz O; Berman B; Pariser DM; Goldenberg G; Rosen T; Rigel DS
    Dermatol Clin; 2017 Oct; 35(4):565-576. PubMed ID: 28886814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of gene expression profile testing as a prognostic tool in early-stage cutaneous melanoma - compelling but not ready for primetime.
    Christensen L; Scott J; Bordeaux J
    Melanoma Res; 2018 Dec; 28(6):652-654. PubMed ID: 30211811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene Expression Profiling in Cutaneous Melanoma: Caveats for Clinicians.
    Sominidi-Damodaran S; Pittelkow MR; Meves A
    Mayo Clin Proc; 2016 Aug; 91(8):1147-8. PubMed ID: 27492918
    [No Abstract]   [Full Text] [Related]  

  • 32. Early outcome of a 31-gene expression profile test in 86 AJCC stage IB-II melanoma patients. A prospective multicentre cohort study.
    Podlipnik S; Carrera C; Boada A; Richarz NA; López-Estebaranz JL; Pinedo-Moraleda F; Elosua-González M; Martín-González MM; Carrillo-Gijón R; Redondo P; Moreno E; Malvehy J; Puig S
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):857-862. PubMed ID: 30702163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of melanoma: can we use gene expression profiling to help guide treatment and surveillance?
    Zager JS; Hyams DM
    Clin Exp Metastasis; 2024 Aug; 41(4):439-445. PubMed ID: 38064126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression profiling of primary cutaneous melanoma.
    Winnepenninckx V; Van den Oord JJ
    Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.
    Scala S; Ottaiano A; Ascierto PA; Cavalli M; Simeone E; Giuliano P; Napolitano M; Franco R; Botti G; Castello G
    Clin Cancer Res; 2005 Mar; 11(5):1835-41. PubMed ID: 15756007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic analysis of metastatic versus nonmetastatic conjunctival melanoma using a cutaneous melanoma gene expression panel.
    Waninger JJ; Demirci FY; Demirci H
    Can J Ophthalmol; 2024 Oct; ():. PubMed ID: 39366666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic gene expression profile testing to inform use of adjuvant therapy: A survey of melanoma experts.
    Fastner S; Shen N; Hartman RI; Chu EY; Kim CC; Kirkwood JM; Grossman D
    Cancer Med; 2023 Dec; 12(24):22103-22108. PubMed ID: 38098216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular diagnosis of melanoma-have we arrived?
    Bordelon JR; Grichnik JM
    Dermatol Ther; 2015; 28(6):405. PubMed ID: 26031627
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of Genetic Aberrations in the Assessment and Prognosis of Melanoma.
    High WA
    Dermatol Clin; 2017 Oct; 35(4):525-536. PubMed ID: 28886809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of DNA repair pathways is associated with metastasis in melanoma patients.
    Kauffmann A; Rosselli F; Lazar V; Winnepenninckx V; Mansuet-Lupo A; Dessen P; van den Oord JJ; Spatz A; Sarasin A
    Oncogene; 2008 Jan; 27(5):565-73. PubMed ID: 17891185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.